about
Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without RecurrenceAnalgesic opioid dose is an important indicator of postoperative ileus following radical cystectomy with ileal conduit: experience in the robotic surgery era.Trends of presentation and clinical outcome of treated renal angiomyolipomaFeasibility of robot-assisted radical prostatectomy for very-high risk prostate cancer: surgical and oncological outcomes in men aged ≥70 years.Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.Obesity is not associated with increased operative complications in single-site robotic partial nephrectomy.Accuracy of Urinary Neutrophil Gelatinase-Associated Lipocalin in Quantifying Acute Kidney Injury after Partial Nephrectomy in Patients with Normal Contralateral Kidney.Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levelsPrognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate CancerNonvisible tumors on multiparametric magnetic resonance imaging does not predict low-risk prostate cancer.Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy.Unrecognized kinetics of serum testosterone: impact on short-term androgen deprivation therapy for prostate cancer.Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsyLaparoendoscopic management of midureteral strictures.The prognostic effect of prostate-specific antigen half-life at the first follow-up visit in newly diagnosed metastatic prostate cancer.Urologic cancers in Korea.Significance of Neutrophil-to-Lymphocyte Ratio as a Novel Indicator of Spontaneous Ureter Stone Passage.Impact of preoperative calculation of nephron volume loss on future of partial nephrectomy techniques; planning a strategic roadmap for improving functional preservation and securing oncological safety.Comprehensive analysis and validation of contemporary survival prognosticators in Korean patients with metastatic renal cell carcinoma treated with targeted therapy: prognostic impact of pretreatment neutrophil-to-lymphocyte ratio.Effect of Climatic Parameters on Acute Urinary Retention Incidence.Tubeless percutaneous nephrolithotomy with non-absorbable hemostatic sealant (Quikclot®) versus nephrostomy tube placement: a propensity score-matched analysis.Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist's perspective.Transurethral resection of the prostate for patients with Gleason score 6 prostate cancer and symptomatic prostatic enlargement: a risk-adaptive strategy for the era of active surveillance.Can microfocal prostate cancer be regarded as low-risk prostate cancer?Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors.Extended lymph node dissection in robot-assisted radical prostatectomy: lymph node yield and distribution of metastases.Analysis of different tumor volume thresholds of insignificant prostate cancer and their implications for active surveillance patient selection and monitoring.Efficacy of octreotide for management of lymphorrhea after pelvic lymph node dissection in radical prostatectomy.Oncological outcomes after partial vs radical nephrectomy in renal cell carcinomas of ≤7 cm with presumed renal sinus fat invasion on preoperative imaging.Assessing the anatomical characteristics of renal masses has a limited effect on the prediction of pathological outcomes in solid, enhancing, small renal masses: results using the PADUA classification system.Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.Number of positive preoperative biopsy cores is a predictor of positive surgical margins (PSM) in small prostates after robot-assisted radical prostatectomy (RARP).A simple procedure to prevent postoperative inguinal hernia after robot-assisted laparoscopic radical prostatectomy: a plugging method of the internal inguinal floor for patients with patent processus vaginalis.External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses.Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry.Treatment outcomes of chemical castration on Korean sex offenders.Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?Risk and Management of Postoperative Urinary Retention Following Spinal Surgery.Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008.
P50
Q28551111-48ECAE50-9952-499D-8CE8-24108DD8529FQ33941669-EE7F9B66-31BE-4D71-8E30-5D073E397A98Q34015098-4940D23D-8D72-4B3A-8DAA-17790FE4CFCDQ34294893-C47C0F35-D648-4B9C-80DD-52A931299CA2Q35040765-80BAE0F4-D4D9-4716-A684-A60BA3D83735Q35086046-417C9C0B-454C-4165-A798-F381FBFA77D8Q35705301-4B3A1273-9230-47D2-AB80-B723964DA7BAQ35827731-EB0E2945-DB25-4A04-B67B-C05AED8425EEQ35971011-8DA44B20-2EE0-419E-BBB1-627C11AF1E75Q36387925-483365D3-26BD-41A0-BE3F-D7105934181EQ37124741-BDF88238-DBBA-412A-A1AD-538EC7E2BA09Q37284763-44038F96-4E32-4FC2-9028-EAD6C8068B3CQ37708192-57BC819E-EE81-4898-8DF5-9C45F8043DE1Q37710933-F0EF97C5-57ED-4A72-98D8-2E74D05C92C8Q38182096-BAABE431-52A0-4B5D-939E-9D114081E669Q38500334-70AC371B-51DF-4CB2-B0B7-D9EB6C2F536EQ38539129-3D200E74-AFD8-4BD6-B903-629BB02D0530Q38644958-92C22EDB-C926-46AF-B43F-54CFE446A5EDQ38668951-E9923650-FFE0-4E89-8B17-900A51564A35Q39945553-8D53DF9C-FABD-4B99-BA42-23EF1D8D1CA4Q40048361-7F4FB892-E2C6-43FF-B499-6AA9A03136CAQ40783980-075DEBB9-5612-4A12-A28F-696FC769EE6CQ40830549-9DF554E7-33B8-4F6C-9BB4-FA5301746F06Q40934684-E60F1782-DEE9-439F-A7AE-E48DFCCFF872Q41847495-2BEDB013-415E-4D70-9C7D-6C5146F06EC6Q41996680-12006923-4208-4622-9160-DA4D0F7F237CQ42030440-AC586845-35D2-4582-9C4D-8B53B46A5C73Q42736743-3A42FDA1-D206-41ED-B6BB-3695FD743401Q43117117-4A1103C3-C1A5-4132-AA71-07FB4165B910Q43451909-74B67130-9A4F-46E4-866B-5FAAD6425E2FQ44021304-B8FD0611-CBF7-4F16-8265-91DB334F8F51Q44568830-DFABDED9-D946-4F95-AFE8-A6EE4B7A1521Q44714740-043BC0BC-DB76-48CF-85E8-FC5DBE251AC1Q44795864-C4218181-725B-422C-A60C-47B9BA59514EQ44888718-B723D335-61EF-4B33-A103-C2CEBED096C7Q47692316-4C137E7C-2DD7-47DD-BC71-BEF20CC3293FQ47872216-EC6879CF-3C4B-4365-9C0F-7F9479C87F4BQ48066815-68D935E9-B6B5-4ABD-9372-03C89DDC3FBAQ48315672-6DFC39B2-920D-4368-9136-B94FB1F6EB93Q49185314-A138D0E6-FC63-41B5-9404-3F9453A706D0
P50
description
researcher ORCID ID = 0000-0001-7303-6256
@en
wetenschapper
@nl
name
Kyo Chul Koo
@ast
Kyo Chul Koo
@en
Kyo Chul Koo
@es
Kyo Chul Koo
@nl
type
label
Kyo Chul Koo
@ast
Kyo Chul Koo
@en
Kyo Chul Koo
@es
Kyo Chul Koo
@nl
prefLabel
Kyo Chul Koo
@ast
Kyo Chul Koo
@en
Kyo Chul Koo
@es
Kyo Chul Koo
@nl
P106
P31
P496
0000-0001-7303-6256